The heat shock protein antagonist 17-AAG potentiates the activity of enzastaurin against malignant human glioma cells
- 6 May 2008
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 268 (1) , 46-55
- https://doi.org/10.1016/j.canlet.2008.03.039
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- AG490 influences UCN-01-induced cytotoxicity in Glioma cells in a p53-dependent fashion, correlating with effects on BAX cleavage and BAD phosphorylationCancer Letters, 2007
- Synergistic antiglioma activity of radiotherapy and enzastaurinAnnals of Neurology, 2007
- Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl)Blood, 2006
- The Selective Protein Kinase C β Inhibitor Enzastaurin Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines through the AKT PathwayJournal of Investigative Dermatology, 2006
- Protein kinase Cɛ interacts with Bax and promotes survival of human prostate cancer cellsOncogene, 2003
- Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatmentOncogene, 2002
- Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperoneOncogene, 2000
- Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome cPublished by Elsevier ,1996
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995
- Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitroNeurosurgery, 1991